Investor Hits Advanced Cell With $12M Stock Fraud Suit

Law360, New York (August 24, 2011, 1:21 PM EDT) -- An investor who had an antidilution agreement from a previous legal settlement with Advanced Cell Technology Inc. sued the company Tuesday in Massachusetts for $12.4 million for allegedly misleading him about a stock offering and causing him to buy shares at an inflated price.

Gary D. Aronson, a Nevada man who invests in startup biotechnology companies, launched the suit in federal court against ACT and Wilmington Trust NA, the special administrator of the estate of former ACT CEO William M. Caldwell IV, who died in December....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Aronson et al v. Advanced Cell Technology, Inc. et al


Case Number

1:11-cv-11492

Court

Massachusetts

Nature of Suit

Securities/Commodities

Judge

Nathaniel M. Gorton

Date Filed

August 23, 2011

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.